pcDNA3.1-3*Flag-HIF1A-WT Plasmid
Catalog No. PVTB00599-2a
Vector Backbone pcDNA3.1(+)-3*Flag
Backbone manufacturer Invitrogen
Vector type Mammalian Expression
Backbone size w/o insert 5428bp
Cloning site 5 EcoR I
Site destroyed during cloning NO
Cloning site 3 Xho I
Bacterial resistance Ampicillin
Growth strain Top10
Growth temperature 37 Centigrade
High or low copy High Copy
Selectable markers Neomycin
Background Mammalian Expression vector of Homo sapiens hypoxia inducible factor 1 alpha subunit with N terminal 3xFlag tag
Gene Information
Alternative Gene Name HIF1; MOP1; PASD8; HIF-1A; bHLHe78; HIF-1alpha; HIF1-ALPHA
Insert Gene name HIF1A-WT
Insert size 2481bp
Accessions NM_001530.3
Tag 3*Flag(N-term)
Species Homo sapiens (human)
Gene ID 3091
pcDNA3.1-3*Flag-HIF1A-WT Plasmid Sequence
1 gactacaaag accatgacgg tgattataaa gatcacgaca tcgactacaa ggatgacgat
61 gacaagaagc ttggtaccga gctcggatcc gccaccatgg agggcgccgg cggcgcgaac
121 gacaagaaaa agataagttc tgaacgtcga aaagaaaagt ctcgagatgc agccagatct
181 cggcgaagta aagaatctga agttttttat gagcttgctc atcagttgcc acttccacat
241 aatgtgagtt cgcatcttga taaggcctct gtgatgaggc ttaccatcag ctatttgcgt
301 gtgaggaaac ttctggatgc tggtgatttg gatattgaag atgacatgaa agcacagatg
361 aattgctttt atttgaaagc cttggatggt tttgttatgg ttctcacaga tgatggtgac
421 atgatttaca tttctgataa tgtgaacaaa tacatgggat taactcagtt tgaactaact
481 ggacacagtg tgtttgattt tactcatcca tgtgaccatg aggaaatgag agaaatgctt
541 acacacagaa atggccttgt gaaaaagggt aaagaacaaa acacacagcg aagctttttt
601 ctcagaatga agtgtaccct aactagccga ggaagaacta tgaacataaa gtctgcaaca
661 tggaaggtat tgcactgcac aggccacatt cacgtatatg ataccaacag taaccaacct
721 cagtgtgggt ataagaaacc acctatgacc tgcttggtgc tgatttgtga acccattcct
781 cacccatcaa atattgaaat tcctttagat agcaagactt tcctcagtcg acacagcctg
841 gatatgaaat tttcttattg tgatgaaaga attaccgaat tgatgggata tgagccagaa
901 gaacttttag gccgctcaat ttatgaatat tatcatgctt tggactctga tcatctgacc
961 aaaactcatc atgatatgtt tactaaagga caagtcacca caggacagta caggatgctt
1021 gccaaaagag gtggatatgt ctgggttgaa actcaagcaa ctgtcatata taacaccaag
1081 aattctcaac cacagtgcat tgtatgtgtg aattacgttg tgagtggtat tattcagcac
1141 gacttgattt tctcccttca acaaacagaa tgtgtcctta aaccggttga atcttcagat
1201 atgaaaatga ctcagctatt caccaaagtt gaatcagaag atacaagtag cctctttgac
1261 aaacttaaga aggaacctga tgctttaact ttgctggccc cagccgctgg agacacaatc
1321 atatctttag attttggcag caacgacaca gaaactgatg accagcaact tgaggaagta
1381 ccattatata atgatgtaat gctcccctca cccaacgaaa aattacagaa tataaatttg
1441 gcaatgtctc cattacccac cgctgaaacg ccaaagccac ttcgaagtag tgctgaccct
1501 gcactcaatc aagaagttgc attaaaatta gaaccaaatc cagagtcact ggaactttct
1561 tttaccatgc cccagattca ggatcagaca cctagtcctt ccgatggaag cactagacaa
1621 agttcacctg agcctaatag tcccagtgaa tattgttttt atgtggatag tgatatggtc
1681 aatgaattca agttggaatt ggtagaaaaa ctttttgctg aagacacaga agcaaagaac
1741 ccattttcta ctcaggacac agatttagac ttggagatgt tagctcccta tatcccaatg
1801 gatgatgact tccagttacg ttccttcgat cagttgtcac cattagaaag cagttccgca
1861 agccctgaaa gcgcaagtcc tcaaagcaca gttacagtat tccagcagac tcaaatacaa
1921 gaacctactg ctaatgccac cactaccact gccaccactg atgaattaaa aacagtgaca
1981 aaagaccgta tggaagacat taaaatattg attgcatctc catctcctac ccacatacat
2041 aaagaaacta ctagtgccac atcatcacca tatagagata ctcaaagtcg gacagcctca
2101 ccaaacagag caggaaaagg agtcatagaa cagacagaaa aatctcatcc aagaagccct
2161 aacgtgttat ctgtcgcttt gagtcaaaga actacagttc ctgaggaaga actaaatcca
2221 aagatactag ctttgcagaa tgctcagaga aagcgaaaaa tggaacatga tggttcactt
2281 tttcaagcag taggaattgg aacattatta cagcagccag acgatcatgc agctactaca
2341 tcactttctt ggaaacgtgt aaaaggatgc aaatctagtg aacagaatgg aatggagcaa
2401 aagacaatta ttttaatacc ctctgattta gcatgtagac tgctggggca atcaatggat
2461 gaaagtggat taccacagct gaccagttat gattgtgaag ttaatgctcc tatacaaggc
2521 agcagaaacc tactgcaggg tgaagaatta ctcagagctt tggatcaagt taactgagcg
2581 gccgctcgag tctagagccc
Technical Principle & Methodology
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway:
Recombinant DNA Molecular Cloning and Expression Vector Architecture
(重组DNA分子克隆与表达载体工程构建技术). This ensures maximum reproducibility across clinical research and scientific workflows.